Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


11.05.2026

1 Acta Haematol
1 Am J Hematol
3 Ann Hematol
2 Blood
3 Bone Marrow Transplant
1 Cancer
4 Eur J Haematol
1 Genes Chromosomes Cancer
1 Int J Hematol
1 J Clin Oncol
2 Leuk Res
4 Leukemia
1 Oncogene
1 Oncol Rep


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. COOMBS CC, LeBlanc TW, Winfree KB, Muehlenbein CE, et al
    Treatment Decision-making for Individuals with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the United States.
    Acta Haematol. 2026 May 7:1-21. doi: 10.1159/000552243.
    PubMed         Abstract available


    Am J Hematol

  2. ZHANG TJ, Zhao YJ, Xu ZJ, Qian J, et al
    Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC.
    Am J Hematol. 2026;101:1421-1425.
    PubMed         Abstract available


    Ann Hematol

  3. XUE C, Wu C, Zhang Y, Yang W, et al
    Short-term blinatumomab for B-cell acute lymphoblastic leukemia pediatric patients results in measurable residual disease clearance.
    Ann Hematol. 2026 May 6. doi: 10.1007/s00277-026-07028.
    PubMed         Abstract available

  4. GUGOLE E, Tamellini E, Jance S, Serafin N, et al
    Serositis as possible manifestation in MDS/AML patients with complex karyotype and TP53 mutation: case series.
    Ann Hematol. 2026;105:280.
    PubMed         Abstract available

  5. NIE J, Gao L, Shao Y, Yang L, et al
    CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia.
    Ann Hematol. 2026;105:281.
    PubMed         Abstract available


    Blood

  6. RIBERA JM, Torrent A, Morgades M, Barrena S, et al
    Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Blood. 2026 May 4:blood.2025032645. doi: 10.1182/blood.2025032645.
    PubMed         Abstract available

  7. AL HADIDI S, van Rhee F, Anderson LD Jr
    How I Treat Plasma Cell Leukemia.
    Blood. 2026 May 1:blood.2025032145. doi: 10.1182/blood.2025032145.
    PubMed         Abstract available


    Bone Marrow Transplant

  8. COLMENARES R, Barragan E, Rodriguez-Veiga R, Torres-Minana L, et al
    Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.
    Bone Marrow Transplant. 2026 May 7. doi: 10.1038/s41409-026-02871.
    PubMed         Abstract available

  9. STYCZYNSKI J, Tridello G, Verheggen I, Knelange N, et al
    Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective stu
    Bone Marrow Transplant. 2026 May 4. doi: 10.1038/s41409-026-02898.
    PubMed        

  10. TAUVERON-JALENQUES U, Aspas Requena G, Gross Z, Tavernier E, et al
    Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.
    Bone Marrow Transplant. 2026 Mar 24. doi: 10.1038/s41409-026-02834.
    PubMed         Abstract available


    Cancer

  11. MARVIN-PEEK J, DiNardo CD, Loghavi S, Ravandi F, et al
    Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.
    Cancer. 2026;132:e70434.
    PubMed         Abstract available


    Eur J Haematol

  12. BATYRBEKOVA N, Landtblom AR, Hultcrantz M, Szulkin R, et al
    Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study.
    Eur J Haematol. 2026;116:850-862.
    PubMed         Abstract available

  13. EHLERS LH, Levin MD, van der Klift M, Jensen MB, et al
    Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naive Fit Patients With CLL Without TP53 Aberrations.
    Eur J Haematol. 2026;116:873-882.
    PubMed         Abstract available

  14. BISCHOF L, Egger-Heidrich K, Schneider M, Friedrich G, et al
    Digital Surveillance After Allogeneic Hematopoietic Stem Cell Transplantation Guides Therapeutic Interventions to Reduce Non-Relapse Mortality.
    Eur J Haematol. 2026;116:937-942.
    PubMed         Abstract available

  15. UCHIDA Y, Tateo S, Wakao M, Shinchi H, et al
    Development of Chimeric Antigen Receptor-Modified NK Cells for the Immunotherapy of Adult T-Cell Leukemia/Lymphoma.
    Eur J Haematol. 2026 May 3. doi: 10.1111/ejh.70199.
    PubMed         Abstract available


    Genes Chromosomes Cancer

  16. BALDI A, Stengel A, Muller ML, Hoermann G, et al
    Complex Karyotype in CLL-How to Count Cytogenetic Aberrations Consistently and Efficiently.
    Genes Chromosomes Cancer. 2026;65:e70129.
    PubMed         Abstract available


    Int J Hematol

  17. YANADA M, Shimomura Y, Yamasaki S, Mizuno S, et al
    Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.
    Int J Hematol. 2026 May 4. doi: 10.1007/s12185-026-04223.
    PubMed         Abstract available


    J Clin Oncol

  18. WISEMAN DH, Batta K
    From Molecular Complexity to Personalized Care in Chronic Myelomonocytic Leukemia.
    J Clin Oncol. 2026 May 7:JCO2600635. doi: 10.1200/JCO-26-00635.
    PubMed        


    Leuk Res

  19. OZMEN D, Kurekci DD, Ozkocaman V, Altindag Avci B, et al
    Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.
    Leuk Res. 2026;166:108239.
    PubMed         Abstract available

  20. SLATER VE, McDowell BD, Chrischilles EA
    Assessing the value of measuring frailty in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Leuk Res. 2026;166:108238.
    PubMed         Abstract available


    Leukemia

  21. WU H, Hu C, Wang A, Weisberg EL, et al
    Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.
    Leukemia. 2026 May 6. doi: 10.1038/s41375-026-02980.
    PubMed        

  22. IIDA K, Nakanishi M, Nakahara J, Asada S, et al
    MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2.
    Leukemia. 2026 May 5. doi: 10.1038/s41375-026-02977.
    PubMed         Abstract available

  23. MOHAMED SMA, Schofield P, Evans K, Friedrich KH, et al
    A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia.
    Leukemia. 2026 May 5. doi: 10.1038/s41375-026-02976.
    PubMed        

  24. DUONG N, Khan DH, Thomas GE, Feng Y, et al
    Intracellular IL-23R is necessary for mitotic spindle formation and viability in AML.
    Leukemia. 2026;40:906-917.
    PubMed         Abstract available


    Oncogene

  25. BAI J, Araki K, Kurotaki D, Eerdunduleng, et al
    Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state.
    Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03763.
    PubMed         Abstract available


    Oncol Rep

  26. XUE H, Hua LM, Guo M, Luo JM, et al
    [Retracted] SHIP1 is targeted by miR?155 in acute myeloid leukemia.
    Oncol Rep. 2026;56:124.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum